CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in IOVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,393,768
+$3,622,876 QoQ
Shares Held
3,219,656
+15.7% QoQ
Ownership
0.711%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. IOVA ranks #95 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in IOVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,393,768 | 3,219,656 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,770,892 | 2,783,730 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,516,626 | 2,753,343 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,434,856 | 2,504,542 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,296,355 | 1,916,486 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,152,977 | 1,847,741 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $14,721,116 | 1,989,340 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $17,964,422 | 1,913,144 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $15,919,258 | 1,984,945 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $28,352,142 | 1,913,100 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $14,203,296 | 1,747,023 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $7,701,025 | 1,692,533 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $10,498,202 | 1,491,222 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,451,255 | 1,055,852 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,740,453 | 1,054,844 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,843,066 | 1,027,460 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,045,210 | 1,000,472 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,779,808 | 707,496 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,085,412 | 685,459 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $16,420,995 | 665,896 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $19,655,924 | 755,416 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $22,436,112 | 708,658 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $30,125,524 | 649,257 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $21,031,600 | 638,870 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $17,169,618 | 625,487 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $22,224,761 | 742,310 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||